[2 antihypertensive therapeutic regimes compared in a controlled clinical trial in general practice. Cyclopenthiazide + KC1/methyldopa versus oxprenolol/hydralazine].
D000328:Adult; D002986:Clinical Trials as Topic; D003518:Cyclopenthiazide / Q000627:therapeutic use*; D004232:Diuretics; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004470:Economics, Medical; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D008750:Methyldopa / Q000627:therapeutic use*; D008875:Middle Aged; D010096:Oxprenolol / Q000627:therapeutic use*; D011189:Potassium Chloride / Q000627:therapeutic use*; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use*; D013997:Time Factors
D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D006830:Hydralazine; D010096:Oxprenolol; D008750:Methyldopa; D011189:Potassium Chloride; D003518:Cyclopenthiazide
To antihypertensive behandlingsprincipper sammenlignet ved kontrolleret klinisk forsog i almen praksis. Cyklopentiazid + KC1/metyldopa versus oksprenolol/hydralazin